Participant Flowin a Randomized Clinical Trial of Hydroxychloroquine vs Placebo in Patients Hospitalized With Respiratory Symptoms of Coronavirus Disease 2019 (COVID-19). (JAMA)
JAMA-(ENEWSPF)- A study just released by the Journal of the American Medical Association concluded that the once-touted hydroxychloroquine made no significant difference in patients who were hospitalized with COVID-19. The drug made no difference in outcomes of patients regardless of the patients' age, sex, race/ethnicity, baseline illness severity, and duration of symptoms.
According to the authors of the study, "In this multicenter, blinded, placebo-controlled randomized clinical trial conducted at . . .
